Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
ASKA Executes Capital Increase to FTS AMBROSE HOLDINGS, INC.
ASKA Pharmaceutical Receives “Platinum Kurumin Plus” Certification
ASKA Pharmaceutical rises for a 4th consecutive day to a fresh yearly high on increased stake by UK-based Nippon Active Value Fund
ASKA Pharmaceutical Holdings Selected for“Highly Improved Sustainability Disclosure” by GPIF’s Asset Managers
ASKA Selected under FY2025 Next Nadeshiko Companies Supporting Dual-career and Co-parenting
Insilico Medicine and ASKA Pharmaceutical Expand Partnership to Discover Novel Targets for Women’s Health
ASKA Formulates Long-Term Vision "ASKA VISION 2035" and "Medium-Term Management Plan 2028"
Pfizer and ASKA Pharmaceutical Announce Co-promotion of RSV Vaccine "ABRYSVO Intramuscular Injection"
Personnel Change of ASKA Pharmaceutical
Notice regarding Transition to Company with Audit Committee
Notice regarding Introduction of Restricted Stock Incentive Plan for Employee Stock Ownership Association
Personnel Changes of ASKA Pharmaceutical
Personnel Change of ASKA Pharmaceutical Holdings
Teijin Pharma and ASKA Pharmaceutical Enter Joint Research Agreement to Accelerate Discovery of Novel Small-Molecule Drug Candidates for Gynecological
Supplementary Documents of Consolidated Financial Results for the Third Quarter of FY2025
Consolidated Financial Results for the Third Quarter of FY2025
ASKA Pharma, Apr-Dec (Cumulative 3Q) Ordinary Profit Decreases by 11%
ASKA Achieves Score of B in Climate Change B- in Water Security and C in Forests at CDP2025
ASKA Pharmaceutical Launches LEUPRORELIN ACETATE SR FOR INJECTION KIT
ASKA Pharmaceutical Holdings Participates in Jefferies Global Healthcare Conference in London